Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CO-1.01 vs Gemcitabine in Metastatic Pancreatic Cancer
NCT01124786Phase 2Completed
- Sponsor
- Clovis Oncology
- Start
- May 2010
- Primary completion
- Nov 2012
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of gemcitabine elaidate in pancreatic ductal adenocarcinoma (PDAC), sponsored by Clovis Oncology. Started May 2010; status: completed.
02
Drugs
gemcitabine elaidate
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01124786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124786.